Rapid Antigen Test

The COVID-19 Antigen Rapid Test is an in-vitro immunoassay. The assay is for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from human upper and/or lower respiratory secretions. In other words, this will test active infection. Anti-SARS-CoV-2 antibodies are immobilized on the test region of the nitrocellulose membrane. Anti-SARS-CoV-2 antibodies conjugated to coloured particles are immobilized on the conjugated pad. A sample is added to the extraction buffer which is optimized to release the SARS-CoV-2 antigens from the specimen. Administered by a licensed Medical Practitioner and tested at Point of Care, the COVID-19 Antigen Rapid Test is only for use under the Food and Drug Administration’s Emergency Use Authorization. Results are available to you in fifteen (15) minutes.